Systemic Sclerosis-Associated Pulmonary Arterial Hypertension Completed Phase 2 Trials for Acetaminophen (DB00316)

IndicationStatusPhase
DBCOND0046831 (Systemic Sclerosis-Associated Pulmonary Arterial Hypertension)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01086540Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)Treatment